EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Regional Citrate Anticoagulation During Continuous Renal Replacement Therapy; Should It Be the First Choice Over Heparin in Children?

Guntulu Sık iD

Therapeutic Apheresis and Dialysis · 2025

DOI: 10.1111/1744-9987.70087 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Therapeutic Apheresis and Dialysis, 2025. Verfasst von Guntulu Sık. Beteiligte Einrichtung: Department of Pediatric Intensive Care, School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey. Hauptthemen laut MEDLINE: Heparin, Anticoagulants, Continuous Renal Replacement Therapy, Citric Acid. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regional citrate anticoagulation (RCA) has gained increasing attention as a superior anticoagulation strategy in pediatric continuous renal replacement therapy (CRRT). Compared to systemic heparin anticoagulation (SHA), RCA offers significant advantages, including prolonged circuit lifespan, reduced clotting rates, and a lower incidence of bleeding complications. While heparin remains widely used due to its availability and ease of administration, its systemic effects, particularly the risk of bleeding and heparin‐induced thrombocytopenia, pose considerable challenges in critically ill children. Studies have consistently demonstrated that RCA reduces transfusion requirements and enhances circuit survival without increasing bleeding risk. Despite potential metabolic concerns such as citrate accumulation, metabolic alkalosis, and electrolyte imbalances, these risks can be effectively managed with careful monitoring and protocol adjustments. As pediatric CRRT protocols continue to evolve, RCA is emerging as the preferred first‐line anticoagulation method, particularly in patients with high bleeding risk. The growing body of evidence supports its wider clinical application, promising better treatment outcomes and improved survival rates in critically ill pediatric patients requiring CRRT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeparinAnticoagulantsContinuous Renal Replacement TherapyCitric AcidRenal Replacement TherapyHumansChildCritical IllnessHemorrhage

Stichwörter der Autor:innen

continuous renal replacement therapypediatric intensive careregional citrate anticoagulationsystemic heparin anticoagulation

Substanzen

HeparinAnticoagulantsCitric Acid

Autor:innen und Institutionen

  • Department of Pediatric Intensive Care, School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.

ORCID-Profile: Guntulu Sık

Zitieren

APA

Sık, G. (2025). Regional Citrate Anticoagulation During Continuous Renal Replacement Therapy; Should It Be the First Choice Over Heparin in Children?. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.70087

Vancouver

Sık G. Regional Citrate Anticoagulation During Continuous Renal Replacement Therapy; Should It Be the First Choice Over Heparin in Children?. Therapeutic Apheresis and Dialysis. 2025. doi:10.1111/1744-9987.70087

BibTeX
@article{Sk2025,
  author = {Sık, Guntulu},
  title = {Regional Citrate Anticoagulation During Continuous Renal Replacement Therapy; Should It Be the First Choice Over Heparin in Children?},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2025},
  doi = {10.1111/1744-9987.70087}
}
Kostenlos starten →